Equities
TechnologyTechnology
  • Price (USD)32.49
  • Today's Change3.96 / 13.88%
  • Shares traded6.59m
  • 1 Year change+79.70%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform3
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for Kyndryl Holdings Inc have a median target of 33.00, with a high estimate of 35.00 and a low estimate of 33.00. The median estimate represents a 15.67% increase from the last price of 28.53.
High22.7%35.00
Med15.7%33.00
Low15.7%33.00

Earnings history & estimates in USD

On Nov 06, 2024, Kyndryl Holdings Inc reported 2nd quarter 2025 losses of -0.19 per share. This result exceeded the -0.24 consensus loss of the 3 analysts covering the company and exceeded last year's 2nd quarter results by 69.35%.
The next earnings announcement is expected on Feb 10, 2025.
Average growth rate-104.03%
Kyndryl Holdings Inc reported annual 2024 losses of -1.48 per share on May 07, 2024.
Average growth rate+51.11%
More ▼

Revenue history & estimates in USD

Kyndryl Holdings Inc had 2nd quarter 2025 revenues of 3.77bn. This bettered the 3.72bn consensus of the 4 analysts covering the company. This was 9.99% below the prior year's 2nd quarter results.
Average growth rate-1.87%
Kyndryl Holdings Inc had revenues for the full year 2024 of 16.05bn. This was 5.72% below the prior year's results.
Average growth rate-7.23%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.